{"id":535440,"date":"2021-09-08T08:03:04","date_gmt":"2021-09-08T12:03:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/"},"modified":"2021-09-08T08:03:04","modified_gmt":"2021-09-08T12:03:04","slug":"aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/","title":{"rendered":"Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>CHARLESTON, S.C., Sept.  08, 2021  (GLOBE NEWSWIRE) &#8212; <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4CK_BgvAOEf9-QdNysjZPcKyqCNbBPTeo-gJJUewuFhRUSrrUtf2D7c0JC6UJLfJqZIwjoCkPtvRwQmGCZKmVo_iMNqmwLtZZbzC8ddEUSI=\" rel=\"nofollow noopener\" target=\"_blank\">Aeterna Zentaris Inc.<\/a> (NASDAQ: AEZS) (TSX: AEZS) (the \u201cCompany\u201d), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VExEzkS3-0rLGUokWkqliKPDlLSfJPrtxxyxSPhI5DIopIkfIEzVlporY7mIjq5JmIYcpeqe2kQG3VSbYeKXB-f6_FTeWamwPBhk06vz9f0=\" rel=\"nofollow noopener\" target=\"_blank\">Dr. Klaus Paulini<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nduLfY2u5ArirmqvpAQYy8PwkINHjBXo-a_laS86vq5Z4BCnKpRYk3Z4Ymft1-n7kYonBRuq9JJJ2gcSBxVVxwrq7k-2awhtUoRuUFQrmG_AdJAPsrdsOpPlEPC_RLUE\" rel=\"nofollow noopener\" target=\"_blank\">, Chief Executive Officer<\/a> of Aeterna, will present at the virtual <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-elAzbpKIC_yw5Ur1nvjwT6rrVPNSWEImVAoe8Ncjkd_fSyBlAwR0zp7-Z9L0d4D__iCw6-Oncry5Gsa53UuwghfIO_WtPAvqw4MqCrOjg4=\" rel=\"nofollow noopener\" target=\"_blank\">H.C. Wainwright <\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Qz5PHmtWn3qz_-gYMkmJDMLK80FXvd1qPkXgG1VGLUo1q1qMcHNOoDEbecKZuusV4-XtekFaDaXCFT-Eu5Zlzw==\" rel=\"nofollow noopener\" target=\"_blank\">23<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sf3Ql0tClGdWGxAVS49YOzEZpu2mvUkTIzUz5g6DssGytrbehtyILYdEj1euxRwlOuYNtvPMxnSLH9wo6YqFpQ==\" rel=\"nofollow noopener\" target=\"_blank\"><sup>rd<\/sup><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lvhmWSdA9cwKN8FjYQwCopHuON0Bq6Xw6X-M2sCCL29zCoWOFZnYkatMrrto_qjLdW3jmpiQDQGDUaN7ZPNVSsF8schd7mff0Ezfo_0akv96fVlZDxbsY2Ns9UrgFd8G\" rel=\"nofollow noopener\" target=\"_blank\"> Annual Global Investment <\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ptlVECIqcAhDjfaMcfOsg4sktDfWLm-Z4NjOf_mHcsZ_zNVhMlE7NaXzfJZEUAQadAY81IS-SKGzUyDXM5axqGi5ScYRYw6UysA1x9J8m_U=\" rel=\"nofollow noopener\" target=\"_blank\">Conference<\/a> taking place September 13-15, 2021.<\/p>\n<p align=\"justify\">In addition to the presentation, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B94O2YYO_cRTj_jVHQpmQk3VpCvsjYNgadWT07UsJf03JspnxyZVPKA0cv_9jHEw_ZmJ_NDEphr1lju9XDxZEytDOd1MMmmKtOLVLVt0zk8=\" rel=\"nofollow noopener\" target=\"_blank\">conference website<\/a>.<\/p>\n<p align=\"justify\">A <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9tm4WBLXI9O39i2bwVOu5UMuWEuTgacboprVtU3fNRW0xQwmLajJKGhvIs_vB5dnLOM2r67B6c9z-JDEb8Hy7sAtYINrQ1yheoZYZtP7xdl1MDuWoWopCTjnJ22L5_fOYRKObHNctsdlI4u-z5JRNw==\" rel=\"nofollow noopener\" target=\"_blank\">video webcast<\/a> of the presentation will be available for viewing on-demand beginning Monday, September 13, 2021, at 7:00 AM ET for those registered for the event and will be accessible on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wJ8DAyIUL600mHqfQdjAORiKVzliIsmb9FZ0Km55QD0-R1-bg0-kuRXaWRVhiMuwlleLzXazTvIsA-woquqKVG_2IXvN1muLPrft2CIV0u8=\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a> page in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=__47o_Td8th7z2ETA4y1HHA6m8JfOocxi9Rqdf1nnUT6OysrHMP_4b7C51Tx1g02iRCnbMaNJ4xy2QQtPSfc5jKmCDEo84Jl92y1vRGniXk=\" rel=\"nofollow noopener\" target=\"_blank\">Investors<\/a> section of the Company\u2019s website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oq89sAW7Ntk-qV-PxfUpQKZotuB0JdaZ_KPmsm8UofeD1DDNpRVg3PJFhXIW5iamOVa8RcmZmiI1-QZv74ln9Q==\" rel=\"nofollow noopener\" target=\"_blank\">www.zentaris.com<\/a>). The webcast replay will be archived for 90 days following the event.<\/p>\n<p align=\"justify\">\n        <strong>About Aeterna Zentaris Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Aeterna Zentaris is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company&#8217;s lead product, macimorelin (Macrilen<sup>\u2122<\/sup>), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is leveraging the clinical success and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD) in collaboration with Novo Nordisk. The Company is also leveraging the clinical success and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD), an area of significant unmet need.<\/p>\n<p align=\"justify\">Aeterna Zentaris is dedicated to the development of therapeutic assets and has recently taken steps to establish a growing preclinical pipeline to potentially address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), hypoparathyroidism and amyotrophic lateral sclerosis (ALS; Lou Gehrig&#8217;s disease). Additionally, the Company is developing an oral prophylactic bacterial vaccine against SARS-CoV-2, the virus that causes COVID-19.<\/p>\n<p align=\"justify\">For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oq89sAW7Ntk-qV-PxfUpQPk9iqy-SwfeKKKVS6Fiue8oPAacoEPlFKKQ-UGNnTT-k-JppHldb_i24Eouej7eMHjUqOSmWUca6hhhsygHKCPLk1Qwpb7UIuX3b71A_o66DYCPRwxlYzCfaGbhZkLz3LSpIbShoX-uVTZxZLJAODdCy63N5ac1gWeWTNH0QkcVJyGTCJJQAc0ixg5pVnEDydUEhs8rOvIzRvDJkm5t54U=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.zentaris.com<\/u><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hmrWM4WBTbD8K8HT6rN9-P2AH96NGnQ48YQM-ZGuEA0lUEtQsyWi_9RXuAKdIxkV0N8eyimy7fEeMLPppSmKpvlM9PVoq009k3BWWykxa6glsuPOoW1Aa0iV5Jk_MDH4g-2x8eS9LlsT0ilTaq0I7Tdw7RnYC9t3WsXgMzYFqbV7YYR88aLlzcTH7h6m2TsiiWcnIEjLMUARhTVoDcbxyw==\" rel=\"nofollow noopener\" target=\"_blank\">\u00a0<\/a>and connect with the Company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eNWVMS75RHoyb5CK9tCo64kb-naqUHSElIoisAfgE6ZsKcWZ3Isy_Pm2qU2kZeTgPi3Z1QHm9S6fyph6CTxcnCWh962pGsPYtQBb5JctvG40T2b7Pw_kr_iJgSBs2kTmhkkCBHwbzxsmpyonU7TM24-7fX36MKG9SYwTDymzsIXFZdTfqJEwyL0lZjJAL0a2tkVlc3yOUk18AduM50b-MjrWwlE8DbrxYEOmT2T_KPY=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Twitter<\/u><\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nxNsvpsLuwEr496bfVGtHy2hLOfGPIBvvG2MkG7Y2oZZMPeltfJlmqeTWLz80V0E9GbxOOPV6KWeJCBWLx5ua7eWMh2f6Ht3d5VdQg8ofChMDLTi6cMcMbJvIH2Ran-zFr5vfXePem8z-jllXwT7Rri2DJk_n5armGi9JNpFRARl4iVJamKdvtfpjlV-UAEjqjBtGnl3AE_8KTlKvmYyChxlcnnvIXPiaKjYa7mj6-V1VfX4EeJW8BsSRgIdfbjaGyFfXOJHJtCg__q454s1sA==\" rel=\"nofollow noopener\" target=\"_blank\"><u>LinkedIn<\/u><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wJu3B7x1B67JeP971fj4Qjzz5ydwcTz-iVdkOgZtGOvXTGsj-mndp87AkrqpRBW7L_o_G1pa0iYSMqX3YUqkKSE6G-7laXSRsVBlzDxQcazkR1CSr1e-1ZYiZuKhjm55wlX3N3XxmcGvcjgLWT-o9CQ0KduKXcDXfQQBI2xsp9Gr7ML90ysjVXkPOIrrTo5ZmRWEsiftdDryx-KFpRyB6LzCuBkxNvj7ZF4uPBgpGYszLgCQUnAFNGNl_nmJ-wHdtZPit8pD_Jt925d8umJ4mA==\" rel=\"nofollow noopener\" target=\"_blank\">\u00a0<\/a>and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GyUYJ1qgfKS1p3OZpjz4toY25j5VN87cjT7kwmzJACsQiITX1jJ3AEeQKuNkd46vehGqbdGDlWLT5wkG_H-1N2QQ-x4WHBHqOOZc3cDtnY_wxQ2-QIdHxx59ogIraX9cgx7yCP-WRbd0Y059KvckUrh6MrC7t9zZb_22UWQho6ntMjn_E6CQQrP3WOSPBIzhF8mRb1cMdHvavibXEIYtpkjypMgOvfA993zWPQzfCTk=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Facebook<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact:<\/strong>\n      <\/p>\n<p>Jenene Thomas<br \/>JTC Team<br \/>T (US): +1 (833) 475-8247<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p6uihurcTlkYQ_1tSODVPBVbW7GUjzrk6UhUjvQNOQ3nSa3ICe6yHzlJvagqaTC99IbWdykTPVnNJAKSzVZlAQ==\" rel=\"nofollow noopener\" target=\"_blank\">aezs@jtcir.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc4OCM0MzkzNzI0IzUwMDA3MjY3Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MjJkZGZlNmItN2ExMS00OTA0LWFlZGMtNmY2MDdmYWIxYzJmLTUwMDA3MjY3Nw==\/tiny\/Aeterna-Zentaris-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHARLESTON, S.C., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the \u201cCompany\u201d), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna, will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021. In addition to the presentation, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website. A video webcast of the presentation will be available for viewing on-demand beginning Monday, September 13, 2021, at 7:00 AM &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535440","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHARLESTON, S.C., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the \u201cCompany\u201d), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna, will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021. In addition to the presentation, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website. A video webcast of the presentation will be available for viewing on-demand beginning Monday, September 13, 2021, at 7:00 AM &hellip; Continue reading &quot;Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-08T12:03:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc4OCM0MzkzNzI0IzUwMDA3MjY3Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference\",\"datePublished\":\"2021-09-08T12:03:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/\"},\"wordCount\":383,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTc4OCM0MzkzNzI0IzUwMDA3MjY3Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/\",\"name\":\"Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTc4OCM0MzkzNzI0IzUwMDA3MjY3Nw==\",\"datePublished\":\"2021-09-08T12:03:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTc4OCM0MzkzNzI0IzUwMDA3MjY3Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTc4OCM0MzkzNzI0IzUwMDA3MjY3Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference - Market Newsdesk","og_description":"CHARLESTON, S.C., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the \u201cCompany\u201d), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna, will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021. In addition to the presentation, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website. A video webcast of the presentation will be available for viewing on-demand beginning Monday, September 13, 2021, at 7:00 AM &hellip; Continue reading \"Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-08T12:03:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc4OCM0MzkzNzI0IzUwMDA3MjY3Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference","datePublished":"2021-09-08T12:03:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/"},"wordCount":383,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc4OCM0MzkzNzI0IzUwMDA3MjY3Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/","name":"Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc4OCM0MzkzNzI0IzUwMDA3MjY3Nw==","datePublished":"2021-09-08T12:03:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc4OCM0MzkzNzI0IzUwMDA3MjY3Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc4OCM0MzkzNzI0IzUwMDA3MjY3Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-present-at-the-h-c-wainwright-23rd-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535440"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535440\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}